Stock AnalizMaxlinear, Inc. MXL
Semiconductors · IPO 2010 · data as of November 13, 2026
Maxlinear, Inc. (MXL) is a technology company listed in the US with a market value of about $5.1B. In the twelve months to September 30, 2026 it had revenue of $661M and net income of -$29M, a net margin of -4.4%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -0% a year, a 5-year average ROIC of -6%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 88% below the current price.
Score: 1.0 / 5
Checks passed
- Revenue growth above 10% last year
- Profit margin improving
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $661M | $468M | $361M | $693M | $1.1B | $892M | $479M | $317M | $385M | $420M | $388M |
| Net income | -$29M | -$137M | -$245M | -$73M | $125M | $42M | -$99M | -$20M | -$26M | -$9M | $61M |
| Free cash flow | -$21M | $7M | -$63M | $30M | $347M | $129M | $61M | $71M | $95M | $68M | $109M |
| EPS (diluted) | $-0.30 | $-1.58 | $-2.93 | $-0.91 | $1.55 | $0.53 | $-1.35 | $-0.28 | $-0.38 | $-0.14 | $0.91 |
| Net margin | -4.4% | -29.2% | -68.0% | -10.5% | 11.2% | 4.7% | -20.6% | -6.3% | -6.8% | -2.2% | 15.8% |
| ROIC | — | -20.6% | -26.4% | -3.6% | 15.5% | 6.9% | -11.0% | -2.1% | -2.3% | -2.3% | 17.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 11 analysts is $93.64, 68% above the current price; targets range from $40.00 to $125.00; the consensus rating is “none”; expected EPS is $1.99 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Maxlinear stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 88% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Maxlinear pay a dividend?
Not currently.
Is Maxlinear a good stock to buy?
We do not give buy or sell advice. Maxlinear scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.